Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

Lennart Hansson; Lars Lindholm; Tord Ekbom; Björn Dahlöf; Jan Lanke; Bengt Scherstén; P-O Wester; Thomas Hedner; Ulf dé Fairé

doi:10.1016/s0140-6736(99)10327-1

Keywords

MedicineAtenololMyocardial infarctionStroke (engine)LisinoprilBlood pressureInternal medicineHydrochlorothiazideEnalaprilAntihypertensive drugMetoprololClinical endpointCardiologyRandomized controlled trialAngiotensin-converting enzyme

Affiliated Institutions

Related Publications

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Jan A. Staessen , Robert Fagard , Lutgarde Thijs +15 more

1997 The Lancet 2992 citations

Antihypertensive Therapy with MK 4211

Jérôme Biollaz , Hans R. Brunner , Haralambos Gavras +2 more

Nineteen hypertensive patients were treated with increasing doses of the new angiotensin-converting enzyme inhibitor MK 421. Twenty milligrams orally reduced blood pressure from...

1982 Journal of Cardiovascular Pharmacology 193 citations

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario , Jewell A. Jessup , Mark C. Chappell +5 more

Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...

2005 Circulation 1598 citations

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Vincent J. Canzanello , Sheldon G. Sheps

Hypertension remains a major cause of cardiovascular morbidity and mortality in the United States. Disturbing trends have been reported recently and include declining rates of s...

1998 Cardiology in Review 276 citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf , Richard B. Devereux , Sverre E. Kjeldsen +12 more

2002 The Lancet 5386 citations

Publication Info

Year: 1999
Type: article
Volume: 354
Issue: 9192
Pages: 1751-1756
Citations: 1443
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1443

OpenAlex

Cite This

APA Style

                            
                                
                                    Lennart Hansson, 
                                
                                    Lars Lindholm, 
                                
                                    Tord Ekbom
                                
                                et al.
                            
                            (1999). 
                            Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. 
                            The Lancet
                            , 354
                            (9192)
                            , 1751-1756.
                            https://doi.org/10.1016/s0140-6736(99)10327-1
                        

Identifiers

DOI: 10.1016/s0140-6736(99)10327-1